Tamoxifen and the risk of endometrial cancer in Japanese women with breast cancer

Surgery Today

Volumn 36, Issue 1, 2006, Pages 41-46

  Yamazawa, Koji ^a   Miyazawa, Yukimasa ^a   Suzuki, Masato ^a   Wakabayashi, Maki ^a   Kaku, Hiroshi ^a   Matsui, Hideo ^a   Sekiya, Souei ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Breast cancer; Endometrial cancer; Japanese; Tamoxifen

Indexed keywords

TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CANCER RISK; CANCER SURGERY; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; ENDOMETRIUM CANCER; FEMALE; HUMAN; HYPERTENSION; JAPAN; MEDICAL RECORD; MENOPAUSE; MULTIVARIATE ANALYSIS; OBESITY; PARITY; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; TIME SERIES ANALYSIS; TREATMENT DURATION;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; JAPAN; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TAMOXIFEN;

EID: 29544451201     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-004-3126-5     Document Type: Article

References (16)

1. B Fisher JP Costantino CK Redmond ER Fisher DL Wickerham WM Cronin 1994 Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the national surgical adjuvant breast and bowel project (NSABP) B-14 J Natl Cancer Inst 86 527 37
2. LE Rutqvist H Johansson T Signomklao U Johansson T Fornander N Wilking 1995 Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies J Natl Cancer Inst 87 645 51
3. FE van Leeuwen J Benraadt JW Coebergh LA Kiemeney CH Gimbrere R Otter 1994 Risk of endometrial cancer after tamoxifen treatment of breast cancer Lancet 343 448 52
4. Y Matsuyama T Tominaga Y Nomura H Koyama M Kimura M Sano 2000 Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan Ann Oncol 11 1537 43
5. K Katase Y Sugiyama K Hasumi M Yoshimoto F Kasumi 1998 The incidence of subsequent endometrial carcinoma with tamoxifen use in patients with primary breast carcinoma Cancer 82 1698 703
6. FIGO News 1989 Corpus cancer staging Int J Gynecol Obstet 28 189 93
7. SG Silverberg RJ Kurman 1992 Tumors of the uterine corpus and gestational trophoblastic disease J Rosai LH Sobin Atlas of tumor pathology. 3rd series Armed Forces Institute of Pathology Washington, DC 47 89
8. T Fornander LE Rutqvist B Cedermark U Glas A Mattsson C Silfversward 1989 Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers Lancet 1 117 20
9. L Bernstein D Deapen JR Cerhan SM Schwartz J Liff E [tmp] McGann-Maloney 1999 Tamoxifen therapy for breast cancer and endometrial cancer risk J Natl Cancer Inst 91 1654 62
10. L Bergman ML Beelen MP Gallee H Hollema J Benraadt FE van Leeuwen 2000 Risk and prognosis of endometrial cancer after tamoxifen for breast cancer Lancet 356 881 7
11. H Mignotte C Lasset V Bonadona A Lesur E Luporsi JF Rodier 1998 Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study Int J Cancer 76 325 30
12. SM Ismail 1994 Pathology of endometrium treated with tamoxifen J Clin Pathol 47 827 33
13. L Deligdisch T Kalir CJ Cohen M de Latour GL Bouedec F Penault-Llorca 1999 Endometrial histopathology in 700 patients treated with tamoxifen for breast cancer Gynecol Oncol 78 181 6
14. EG Silva CS Tornos M Follen-Mitchell 1994 Malignant neoplasms of the uterine corpus in patients treated for breast carcinoma: the effects of tamoxifen Int J Gynecol Pathol 13 248 58
15. K Yamazawa H Matsui H Ishikura K Seki S Sekiya 2002 Clear cell adenocarcinoma within a tamoxifen-related polyp Acta Obstet Gynecol Scand 81 985 7
16. Report of the Oncologic Committee (in Japanese). Nippon Sanfujinnka Gakkaisi 2001;53:788-800